Hints and tips:
Related Special Reports
...They have warned that the shake-up of drug pricing will cripple innovation and stall development of life-saving medicines....
...William Pao, Pfizer’s chief development officer, said M&A is an important part of the funding ecosystem that supports the development of innovative therapies by scientists....
...UBSO: 6; L: 7; I: 7; Total: 20The legal team at the bank advised on the sale of UBS and Mitsubishi’s joint venture, Mitsubishi Corp-UBS Realty, to global investment fund KKR for $2bn....
...Finding and assessing prospects in the pharma market takes time, according to Denton, an experienced dealmaker who when working as chief financial officer at pharmacy giant CVS in 2018 oversaw its $68bn...
...Rivian founder and chief executive RJ Scaringe chose Normal for its first factory, buying a former Mitsubishi car plant weeks away from demolition for $16mn in 2017....
...Elizabeth Dellert, who joined as Chief Business Development Officer in January 2022, stays in that role. Museum shows can entice prime works to market and so it is with Wayne Thiebaud....
...Instead of warning investors about risky investment in America’s most valuable company, the SEC warns investors about weak disclosures by Chinese companies....
...Now, about 1,000 scientists, engineers and technicians at PMI’s vast R&D facility in Neuchâtel, work solely on development of reduced-risk products....
...Disappointing results might also act as a catalyst for a shift in funding for Alzheimer’s research, with some scientists arguing that promising areas of study and potential treatments have been crowded out by Big Pharma...
...Toshifumi Tada, head of vaccine business development at Mitsubishi Tanabe Pharma, said its subsidiary Medicago would apply for Canadian approval for its vaccine candidate that is made from a plant from the...
...Medicago, a unit of Mitsubishi Tanabe Pharma that is backed by Philip Morris International, is planning to launch the world’s first plant-based Covid-19 vaccine that is potentially cheaper and easier to...
...Takeda Pharmaceutical has no plans to seek approval in Japan for its dengue fever vaccine, nor does Mitsubishi Tanabe Pharma for an inoculation derived from a tobacco leaf plant....
...The question gave the US pharma group a sense of urgency in the development of a coronavirus vaccine. Speed was crucial, so Pfizer had to change how it worked....
...OxyContin maker Purdue Pharma was all but guaranteed its 2019 case would be overseen by Judge Robert Drain after choosing a court in Westchester county, New York....
...She joins from Agora Digital Capital Markets, where she was head of business development....
...The company’s headquarters is in Irvine, California; its software development and vehicle electronics division is in Palo Alto....
...Now the drugmaker will stand or fall based on its ability to unearth new treatments for serious illnesses, a high-stakes strategy given the patchy record of Big Pharma’s research and development labs....
...Contributors to the catalytic capital tranche include the French Development Agency, Germany’s KfW Development Bank, the Japan Bank for International Cooperation, the Grantham Environmental Trust and the...
...Pfizer and BioNTech will begin the technical transfer, equipment installation and development of the Biovac facility immediately....
...Pharma investors, as well as the 6m people living with Alzheimer’s in the US, are nervously waiting for the regulator’s conclusion....
...Only this week, in a dismal counterpoint to the stunning vaccines news, came a fresh reminder of its role in America’s opioid addiction crisis, when Purdue Pharma pleaded guilty to criminal charges over...
...Of others joined in the chase, including Mitsubishi Tanabe Pharma, I’rom Group and Takeda Pharmaceutical, the last offers the best chances....
...The current crop, despite their remarkable development speed and efficacy, are vulnerable to being rendered useless. Scientists expect a mutant strain to escape their grip....
...At the same time, the sector remains fertile hunting ground for companies promising high-octane growth, with “biting edge innovative research and development”, according to Mr Paulsen....
...Mitsubishi Motors to stop making first mass-produced EV Honda and GM join hands to develop cars in North America Honda to launch first mass-produced electric car in October...
International Edition